Drug companies gave at least $116 million to patient advocacy groups in 2015, according to a database launched Friday by Kaiser Health News. “Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration,” KHN writes. “But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups. The Pre$cription for Power database will be available for downloading in May. The database currently covers 2015 and will be updated as additional data become available.”

Related News Articles

Headline
The Alliance for Addiction Payment Reform, whose members include the AHA, today showcased its value-based payment model for addiction and recovery support…
Headline
The AHA is engaging in early primary states, including Nevada and South Carolina, with ads about affordability and rural health care to ensure issues…
Headline
The House Ways and Means Committee today favorably reported out, as amended, the Consumer Protections Against Surprise Medical Bills Act (H.R. 5826), AHA-…
Headline
The Campaign for Sustainable Rx Pricing today launched an ad campaign calling for Congress to pass bipartisan legislation to “hold Big Pharma accountable…
Headline
The Department of Health and Human Services today issued a proposed rule intended to clarify the rights and obligations of faith-based organizations…
Headline
Kansas Gov. Laura Kelly has reached agreement with Senate Republicans on a bipartisan proposal to expand Medicaid eligibility to low-income uninsured…